000 01410 a2200397 4500
005 20250516205428.0
264 0 _c20141209
008 201412s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-14-251
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Danhong
245 0 0 _aClinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer.
_h[electronic resource]
260 _bBMC cancer
_cApr 2014
300 _a251 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCancer Vaccines
_xadverse effects
650 0 4 _aCell- and Tissue-Based Therapy
650 0 4 _aCytokine-Induced Killer Cells
_ximmunology
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_ximmunology
650 0 4 _aMale
700 1 _aZhang, Bin
700 1 _aGao, Haiyan
700 1 _aDing, Guoliang
700 1 _aWu, Qiong
700 1 _aZhang, Jinchao
700 1 _aLiao, Li
700 1 _aChen, Hu
773 0 _tBMC cancer
_gvol. 14
_gp. 251
856 4 0 _uhttps://doi.org/10.1186/1471-2407-14-251
_zAvailable from publisher's website
999 _c23726230
_d23726230